WealthTrust Fairport’s iShares Biotechnology ETF IBB Stock Holding History

WealthTrust Fairport’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$53K	Buy	472 +251	+114%	+$27.5K	0.01%	233
2018 Q4	$21K	Sell	221 -325	-60%	-$34.5K	﹤0.01%	274
2018 Q3	$67K	Sell	546 -248	-31%	-$29.2K	0.01%	231
2018 Q2	$87K	Sell	794 -13,711	-95%	-$1.47M	0.01%	211
2018 Q1	$1.55M	Buy	14,505 +1,691	+13%	+$187K	0.16%	93
2017 Q4	$1.37M	Buy	12,814 +1,240	+11%	+$133K	0.14%	96
2017 Q3	$1.29M	Buy	11,574 +1,113	+11%	+$119K	0.14%	95
2017 Q2	$1.08M	Buy	+10,461	New	+$1.03M	0.12%	99
2016 Q1	–	Sell	-13,740	Closed	-$1.55M	–	145
2015 Q4	$1.55M	Buy	13,740 +2,916	+27%	+$316K	0.21%	83
2015 Q3	$1.09M	Buy	10,824 +6,462	+148%	+$775K	0.16%	86
2015 Q2	$536K	Buy	+4,362	New	+$522K	0.07%	97
2014 Q2	–	Sell	-525	Closed	-$41K	–	366
2014 Q1	$41K	Sell	525 -8,259	-94%	-$688K	0.01%	158
2013 Q4	$665K	Buy	8,784 +1,431	+19%	+$102K	0.1%	93
2013 Q3	$514K	Buy	7,353 +1,011	+16%	+$66.2K	0.09%	102
2013 Q2	$368K	Buy	+6,342	New	+$367K	0.06%	107

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

DFO

Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

WealthTrust Fairport's IBB Position: Q1 2019 in Review

WealthTrust Fairport increased its iShares Biotechnology ETF (IBB) stake by 114% in Q1 2019, buying an estimated $27.5K and bringing the position to 472 shares worth $53K. The position accounts for 0.01% of the portfolio, ranked #233.

WealthTrust Fairport first reported a position in IBB in Q2 2013 and has held it in 15 quarters since. The position peaked at $1.55M in Q4 2015. 670 funds tracked by Wall St. Rank hold IBB as of Q1 2019.

WealthTrust Fairport held 472 shares of iShares Biotechnology ETF worth $53K as of Q1 2019.
WealthTrust Fairport bought 251 iShares Biotechnology ETF shares in Q1 2019, an estimated $27.5K.
iShares Biotechnology ETF made up 0.01% of WealthTrust Fairport's portfolio in Q1 2019, its #233 holding.
WealthTrust Fairport first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 15 quarters since.
WealthTrust Fairport's iShares Biotechnology ETF position peaked at $1.55M in Q4 2015.
670 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2019.

Based on WealthTrust Fairport's 13F filing for Q1 2019, filed 15 May 2019.